Načítá se...
Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative
BACKGROUND/AIMS: Use of data monitoring committees to oversee clinical trials was first proposed nearly 50 years ago. Since then, data monitoring committee use in clinical trials has increased and evolved. Nonetheless, there are no well-defined criteria for determining the need for a data monitoring...
Uloženo v:
| Vydáno v: | Clin Trials |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5639979/ https://ncbi.nlm.nih.gov/pubmed/28503947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774517707743 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|